Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EFGARTIGIMOD ALFA vs EFLORNITHINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

EFGARTIGIMOD ALFA vs EFLORNITHINE: Safety Overview

Metric EFGARTIGIMOD ALFA EFLORNITHINE
Total FAERS Reports 249 307
Deaths Reported 26 14
Death Rate 10.4% 4.6%
Hospitalizations 115 10
Average Patient Age 54.0 yrs 47.8 yrs
% Female Patients 82.5% 92.1%
FDA Approval Date N/A Dec 13, 2023
Manufacturer argenx US USWM, LLC
Route INTRAVENOUS ORAL
Marketing Status Prescription Discontinued